INDRA statements for KCNG3

This page allows you to curate the loaded statements. For more information please see the manual.

Statements

databases
phosphosite cbn pc11 biopax bel_lc signor biogrid lincs_drug tas hprd trrust ctd virhostnet phosphoelm drugbank omnipath | geneways tees isi trips rlimsp medscan sparser eidos reach
reading
NOG affects KCNG3
3 |
Transcriptionally active NOG decreases the amount of KCNG3. 3 / 3
3 |
biopax:ctd
No evidence text available
27188386
biopax:ctd
No evidence text available
27188386
biopax:ctd
No evidence text available
27188386
Ion channel affects KCNG3
| 1
KCNG3 binds ion channel. 1 / 1
| 1
sparser
"Kv6.3 does not form a functional voltage-gated ion channel when expressed by itself, but when Kv6.3 and Kv2.1 were co-expressed, the heteromultimeric channels display a decreased rate of deactivation compared to that of the homomultimeric Kv2.1 channels."
11852086
Hsa-miR-16-5p affects KCNG3
1 |
Transcriptionally active hsa-miR-16-5p decreases the amount of KCNG3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
20371350
Hsa-miR-103a-3p affects KCNG3
1 |
Transcriptionally active hsa-miR-103a-3p decreases the amount of KCNG3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
20371350
Hsa-miR-101-3p affects KCNG3
1 |
Transcriptionally active hsa-miR-101-3p decreases the amount of KCNG3. 1 / 1
1 |
biopax:mirtarbase
No evidence text available
20371350
TRIM25 affects KCNG3
1 |
TRIM25 binds KCNG3. 1 / 1
1 |
biogrid
No evidence text available
29117863
KCNG3 affects ion channel
| 1
KCNG3 binds ion channel. 1 / 1
| 1
sparser
"Kv6.3 does not form a functional voltage-gated ion channel when expressed by itself, but when Kv6.3 and Kv2.1 were co-expressed, the heteromultimeric channels display a decreased rate of deactivation compared to that of the homomultimeric Kv2.1 channels."
11852086
KCNG3 affects TRIM25
1 |
TRIM25 binds KCNG3. 1 / 1
1 |
biogrid
No evidence text available
29117863
KCNG3 affects THBS2
| 1
KCNG3 increases the amount of THBS2. 1 / 1
| 1
isi
"Among these targets, high expression levels of six genes (THBS2, P4HA3, SERPINH1, CDH11, BCAT1, and KCNG3) were closely associated with a poor prognosis (10-year survival rates) in GC patients (p < 0.05) according to TCGA database analyses."
32235846
KCNG3 affects BCAT1
| 1
KCNG3 increases the amount of BCAT1. 1 / 1
| 1
isi
"Among these targets, high expression levels of six genes (THBS2, P4HA3, SERPINH1, CDH11, BCAT1, and KCNG3) were closely associated with a poor prognosis (10-year survival rates) in GC patients (p < 0.05) according to TCGA database analyses."
32235846
IL1RL1 affects KCNB1, KCNG3, and KCNG4
| 1
KCNG3 binds KCNG4, IL1RL1, and KCNB1. 1 / 1
| 1
sparser
"Using a yeast two-hybrid assay, we found that substitution of the corresponding histidine 105 in Kv2.1 by valine (H105V) or arginine (H105R) disrupted the interaction of the T1 domain of Kv2.1 with the T1 domains of both Kv6.3 and Kv6.4, whereas interaction of the T1 domain of Kv2.1 with itself was unaffected by this mutation."
19074135
BMP2 affects KCNG3
| 1 1
BMP2 increases the amount of KCNG3. 1 / 1
| 1 1
reach
"BMP-2 (100 nM for 18-24 h) significantly (> 2-fold) upregulated mRNA expression of KCNA5, KCNA7, KCNA10, KCNC3, KCNC4, KCNF1, KCNG3, KCNS1, and KCNS3 but downregulated (at least 2-fold) KCNAB1, KCNA2, KCNG2, and KCNV2."
16815889